| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8238574 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
SU11248 (sunitinib) sensitized pancreatic cancer to the cytotoxic effects of radiation. This compound is promising for future clinical trials with chemoradiation in pancreatic cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kyle C. M.D., Ling M.D., Allie B.S., Darren Ph.D., Dennis E. M.D., Anuradha Bapsi M.D.,